bpc-157 clinical trial july 2025 — the most prescribed peptide you've never seen in a trial. 30 total human subjects. Zero RCTs. A Phase 1 that was registered, enrolled, and then quietly canceled with no Net Weight:10mg

DSIP | Neuropeptide Lab Research | Pure Peps

Research Overview NAD+ / MOTS-C / 5-Amino-1MQ — 100/10/10 mg (Lyophilized Powders) Product Specifications Component 1: NAD+ — 100 mg Form: Lyophilized powder Molecular Formula: C21H27N7O14P2 Molecular Weight: 663.4 g/mol Classification: Oxidized dinucleotide research compound Component 2: MOTS-C — 10 mg Form: Lyophilized powder Molecular Formula: C49H85N15O10 Molecular Weight: 1035.3 g/mol Classification: Synthetic mitochondrial-derived peptide analog Component 3: 5-Amino-1MQ — 10 mg Form: Lyophilized powder Molecular Formula: C12H13N3O Molecular Weight: 215.25 g/mol Classification: Synthetic quinazolinone research compound Listing details Amount: 100/10/10mg Analytical Testing A current lot certificate is not attached to this listing

High Yield Peptide

Net Weight:10mg

Many patients report that existing treatments, such as pentosan polysulfate sodium, provide only limited relief, with some experiencing diminishing effects over time